3 | SEC Filings Hub

Filing metadata

Accession number: 0000947871-23-000219
Form type: Form 3
Filer: Kinnate Biopharma Inc.
CIK: CIK 1797768
Filed: Feb 23, 2023
Reporting period: Feb 17, 2023
Description: Initial ownership

Documents

0000947871-23-000219-index.htm

Complete submission

0000947871-23-000219.txt

directory listing

Filed by

Kinnate Biopharma Inc.